AR and posterior cortical atrophy: Whilst there are no commercially available therapies against PEG10, research has shown that transient knockdown approaches can cause growth suppression in AR-null PCa cells such as DU145 and PC3, and stable knockdown was shown to significantly reduce the growth of PC3 cells in a xenograft model [121].